JPMorgan Eurozone Research Enhanced Index Equity ESG UCITS ETF EUR (acc)

Issuer: JPMorgan ETF

Asset Class: Equity

TER: 25bps

Trading Currency: EUR

Pays Income: False

Listing Date: 04 May 2022

Ticker: JREZ

ISIN: IE00004PGEY9

This investment product offers actively managed exposure to the Eurozone equity market, designed for investors seeking to outperform a traditional market-cap-weighted index. It employs a 'Research Enhanced Index' (REI) strategy, which leverages a proprietary, systematic process to select and weight stocks from the MSCI EMU Index universe. The core objective is to achieve long-term returns exceeding the benchmark while maintaining a similar risk profile, including sector and country exposures. This approach combines the benefits of passive investing, such as diversification and low tracking error, with the alpha-seeking potential of active management, focusing on large and mid-capitalization companies across developed European nations within the monetary union.

The portfolio is constructed using a multi-factor methodology that analyzes thousands of data points to assess companies based on fundamental characteristics such as value, quality, and momentum. By systematically overweighting stocks with attractive attributes and underweighting those with weaker profiles, the strategy aims to capture market inefficiencies in a disciplined, rules-based manner. This quantitative approach avoids emotional biases and ensures the portfolio remains well-diversified, without making large, concentrated bets on individual securities. The physical replication method means the fund holds the underlying stocks directly, providing transparency and minimizing counterparty risk.

This fund is well-suited for investors looking for a core Eurozone equity holding that provides a 'smart beta' or factor-based tilt. It serves as a compelling alternative to both purely passive index trackers and higher-cost, high-conviction active funds. The accumulating share class structure makes it particularly attractive for long-term investors focused on capital appreciation, as all dividend income is automatically reinvested back into the fund to harness the effects of compounding.